Hematology-Oncology Fellowship

Overview

Provides clinical, translational and basic laboratory training in haematology, medical oncology, cell therapy and bone marrow transplantation with over 100 faculty and the Duke Cancer Institute.

The programme

Training type

Clinical Fellowship

Duration

3 years

Start

Institution policyDuke GME appointments run 1 July - 30 June, with a few exceptions

Positions

Average of 21 fellows across all training years

Accreditation

Not stated on official page

Department

Divisions of Medical Oncology, Hematological Malignancies and Cellular Therapy, and Hematology

Eligibility and visa

Eligibility

Must have passed USMLE Step 3 (or equivalent) to enter at PGY-3 level or higher (Duke University Hospital policy).

International applicants

NIH-funded years 2-3 restricted to US citizens/permanent residents; other candidates considered if fully funded by their government or medical school.

Visa support

Institution policyJ-1 alien physician status sponsored by ECFMG with Duke's assistance; Duke is H-1B cap-exempt and H-1B is possible for clinical trainees who have passed USMLE Steps 1-3 and hold an ECFMG certificate (individual programmes decide which visas they accept)

Licence requirement

Institution policyNorth Carolina full medical licence or Resident Training License (RTL) required before clinical duties

How to apply

Deadline

Not stated on official page

Application method

ERAS; NRMP Match; four letters requested (one from residency programme director)

Funding

Funding

Years 2-3 primarily NIH-funded; Programme page refers to Duke Graduate Medical Education for stipends and benefits.

Official sources